Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 1,671 | 1,230 | 1,464 | 1,490 | 929 |
| Operating Income | -1,671 | -1,230 | -1,464 | -1,490 | -929 |
| Other Income | 23 | 3 | -4 | -2 | -1 |
| Pre-tax Income | -1,648 | -1,228 | -1,467 | -1,492 | -931 |
| Net Income Continuous | -1,648 | -1,228 | -1,467 | -1,492 | -931 |
| Net Income | $-1,648 | $-1,228 | $-1,467 | $-1,492 | $-931 |
| EPS Basic Total Ops | -0.26 | -0.26 | -0.53 | -0.53 | -0.25 |
| EPS Basic Continuous Ops | -0.26 | -0.26 | -0.53 | -0.53 | -0.25 |
| EPS Diluted Total Ops | -0.26 | -0.26 | -0.53 | -0.53 | -0.25 |
| EPS Diluted Continuous Ops | -0.26 | -0.26 | -0.53 | -0.53 | -0.25 |
| EBITDA(a) | $-1,648 | $-1,206 | $-1,442 | $-1,470 | $-907 |